Envoy Medical Awarded Patent for Recharge System used with Implantable Battery

Growing Portfolio of Patents Further Advances the Company’s Mission to Develop Fully Implanted Devices for Those Suffering from Significant Hearing Loss

WHITE BEAR LAKE, Minnesota, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (NASDAQ: “COCH”), a hearing health company focused on fully implanted hearing systems, today announces it has been awarded another patent from the US Patent & Trademark Office for its fully implanted devices. On September 3^rd, the Company was issued Patent No. 12,081,061, “Recharge System for Implantable Battery,” which relates to predicting a cumulative thermal dose associated with charging an implantable rechargeable energy storage device to a fully charged state and adjusting the amount of current provided to the device during charging. In other words, this can be used to maintain a safe temperature of an implanted rechargeable battery during recharging.